Myanmar vs Panama: Access to anti-retroviral drugs, male
Myanmar
73.0%
in 2024
Panama
72.0%
in 2024
Myanmar rank
62nd
Panama rank
65th
Access to anti-retroviral drugs, male over time
- Myanmar
- Panama
How they compare
Myanmar currently reports 73.0% against 72.0% in Panama, a difference of 1.0%.
The two have swapped places 1 time across 25 shared years of data; in 2000 it was Panama ahead.
Myanmar ranks 62nd and Panama ranks 65th of 141 countries.
Across the 3 decades both report, Myanmar averaged higher in 1 and Panama in 2.
Head to head by decade
| Decade | Myanmar | Panama | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.2% | 14.6% | 12.4% | Panama |
| 2010s | 34.8% | 41.7% | 6.9% | Panama |
| 2020s | 71.2% | 64.6% | 6.6% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Myanmar or Panama?
- Myanmar, at 73.0% against 72.0% in Panama as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Myanmar and Panama?
- 1.0%, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Panama?
- 25 years are reported by both, from 2000 to 2024.
- How do Myanmar and Panama rank globally for access to anti-retroviral drugs, male?
- Myanmar ranks 62nd and Panama ranks 65th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.